Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, Maryland, USA.
Sickle Cell Branch, Division of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, Maryland, USA.
J Magn Reson Imaging. 2022 Jun;55(6):1855-1863. doi: 10.1002/jmri.27950. Epub 2021 Oct 20.
MRI T2* and R2* mapping have gained clinical acceptance for noninvasive assessment of iron overload. Lower field MRI may offer increased measurement dynamic range in patients with high iron concentration and may potentially increase MRI accessibility, but it is compromised by lower signal-to-noise ratio that reduces measurement precision.
To characterize a high-performance 0.55 T MRI system for evaluating patients with liver iron overload.
Prospective.
Forty patients with known or suspected iron overload (sickle cell anemia [n = 5], ß-thalassemia [n = 3], and hereditary spherocytosis [n = 2]) and a liver iron phantom.
FIELD STRENGTH/SEQUENCE: A breath-held multiecho gradient echo sequence at 0.55 T and 1.5 T.
Patients were imaged with T2*/R2* mapping 0.55 T and 1.5 T within 24 hours, and 16 patients returned for follow-up exams within 6-16 months, resulting in 56 paired studies. Liver T2* and R2* measurements and standard deviations were compared between 0.55 T and 1.5 T and used to validate a predictive model between field strengths. The model was then used to classify iron overload at 0.55 T.
Linear regression and Bland-Altman analysis were used for comparisons, and measurement precision was assessed using the coefficient of variation. A P-value < 0.05 was considered statistically significant.
R2* was significantly lower at 0.55 T in our cohort (488 ± 449 s at 1.5 T vs. 178 ± 155 s at 0.55 T, n = 56 studies) and in the patients with severe iron overload (937 ± 369 s at 1.5 T vs. 339 ± 127 s at 0.55 T, n = 23 studies). The coefficient of variation indicated reduced precision at 0.55 T (3.5 ± 2.2% at 1.5 T vs 6.9 ± 3.9% at 0.55 T). The predictive model accurately predicted 1.5 T R2* from 0.55 T R2* (Bland Altman bias = -6.6 ± 20.5%). Using this model, iron overload at 0.55 T was classified as: severe R2* > 185 s , moderate 81 s < R2* < 185 s , and mild 45 s < R2* < 91 s .
We demonstrated that 0.55 T provides T2* and R2* maps that can be used for the assessment of liver iron overload in patients.
2 TECHNICAL EFFICACY: Stage 2.
MRI T2和 R2 映射已被临床用于非侵入性评估铁过载。较低场强 MRI 可能在铁浓度较高的患者中提供更大的测量动态范围,并可能潜在地增加 MRI 的可及性,但信噪比较低会降低测量精度。
为评估肝铁过载患者的高性能 0.55T MRI 系统进行特征描述。
前瞻性。
40 名患有已知或疑似铁过载的患者(镰状细胞贫血[ n=5],β-地中海贫血[ n=3]和遗传性血球增多症[ n=2])和一个肝脏铁模型。
场强/序列:0.55T 和 1.5T 的单次激发多回波梯度回波序列。
患者在 0.55T 和 1.5T 进行 T2*/R2* 映射,24 小时内进行了检查,16 名患者在 6-16 个月内进行了随访检查,共进行了 56 次配对研究。比较了 0.55T 和 1.5T 之间的肝脏 T2和 R2测量值和标准偏差,并使用该数据验证了场强之间的预测模型。然后,使用该模型对 0.55T 时的铁过载进行分类。
使用线性回归和 Bland-Altman 分析进行比较,并使用变异系数评估测量精度。P 值<0.05 被认为具有统计学意义。
我们的队列中,0.55T 时 R2显著较低(1.5T 时为 488±449s,0.55T 时为 178±155s,n=56 项研究),在严重铁过载患者中(1.5T 时为 937±369s,0.55T 时为 339±127s,n=23 项研究)。变异系数表明 0.55T 时的精度降低(1.5T 时为 3.5±2.2%,0.55T 时为 6.9±3.9%)。预测模型能够准确地从 0.55T R2预测 1.5T R2*(Bland-Altman 偏差=-6.6±20.5%)。使用该模型,0.55T 时的铁过载被分为:严重 R2*>185s,中度 81s<R2*<185s,轻度 45s<R2*<91s。
我们证明 0.55T 提供的 T2和 R2图可用于评估患者的肝脏铁过载。
2 技术功效:2 级。